Author: Wu C.S. Pollack A. Czerniak B. Chyle V. Zagars G.K. Dinney C.P.N. Hu S.-X. Benedict W.F.
Publisher: Elsevier
ISSN: 0090-4295
Source: Urology, Vol.47, Iss.3, 1996-03, pp. : 305-310
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
p53 in bladder cancer: mechanism of action, prognostic value, and target for therapy
By Slaton J.W. Benedict W.F. Dinney C.P.N.
Urology, Vol. 57, Iss. 5, 2001-05 ,pp. :
By Kuczyk M. Turkeri L. Hammerer P. Ravery V. on behalf of the European Society for Oncological Urology
European Urology, Vol. 44, Iss. 1, 2003-07 ,pp. :
By Saint F. Le Frere Belda M.A. Quitela R. Gil Diez De Medina S. Hoznek A. Patard J.J. Bellot J. Popov Z. Zafrani E.S. Abbou C.C. Chopin D.
European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. :
A population-based study of patterns of care for muscle-invasive bladder cancer in Sweden
By Jahnson Staffan Damm Ole Hellsten Sverker Holmang Sten Liedberg Fredrik Ljungberg Borje Malmstrom Per-Uno Månsson Wiking Stromberg Fredrik Wijkstom Hans
Scandinavian Journal of Urology and Nephrology, Vol. 43, Iss. 4, 2009-09 ,pp. :